MCRR Refugees Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : MCRR Refugees

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WallStBum who wrote (263)	7/17/1998 10:22:00 AM
From: Madeleine Harrison	Read Replies (1) of 582

Bum, re Nasi: (REUTERS) RESEARCH ALERT - Dain cuts brachytherapy cos RESEARCH ALERT - Dain cuts brachytherapy cos NEW YORK, July 2 (Reuters) - Dain Rauscher Wessels said Thursday it has lowered its rating on three brachytheraphy or cancer treatment providers. -- Theragenics Corp. <THRX.O> cut to neutral from a buy-aggressive. -- Mentor Corp. <MNTR.O> cut to neutral from buy. -- North American Scientific Inc. <NASI.O> cut to neutral from strong buy. -- Analyst Parice Halbert said supply in sector will overtake demand sooner than expected due to rival Anglo-Norwegian health technology company Nycomed Amersham <NYE.N> escalating its capacity expansion sooner than anticipated. -- In addition, an article in June 1998 edition of Urology, comes out in favor of radical prostatectomy over using Iodine seeds on the basis of seven-year disease free rates.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next